Sequential high dose chemotherapy as initial treatment for aggressive sub-types of non-Hodgkin lymphoma: results of the international randomized phase III trial (MISTRAL).

Betticher, D C; Martinelli, G; Radford, J A; Kaufmann, M; Dyer, M J S; Kaiser, U; Aulitzky, W E; Beck, J; von Rohr, A; Kovascovics, T; Cogliatti, S B; Cina, S; Maibach, R; Cerny, T; Linch, D C

Betticher, D C; Martinelli, G; Radford, J A; Kaufmann, M; Dyer, M J S; Kaiser, U; Aulitzky, W E; Beck, J; von Rohr, A; Kovascovics, T; Cogliatti, S B; Cina, S; Maibach, R; Cerny, T; Linch, D C.

Affiliation

Betticher DC; SAKK (Swiss Group for Clinical Cancer Research), Bern, Switzerland. betticherd@hopcantfr.ch

Ann Oncol ; 17(10): 1546-52, 2006 Oct.

Article in En | MEDLINE | ID: mdl-16888080

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Lymphoma, Non-Hodgkin/drug therapy; Neoadjuvant Therapy/methods; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Cyclophosphamide/adverse effects; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin/adverse effects; Drug Administration Schedule; Feasibility Studies; Female; Humans; Lymphoma, Non-Hodgkin/mortality; Lymphoma, Non-Hodgkin/pathology; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy/adverse effects; Prednisone/adverse effects; Recurrence; Salvage Therapy; Survival Analysis; Vincristine/adverse effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Antineoplastic Combined Chemotherapy Protocols / Neoadjuvant Therapy Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Year: 2006 Document type: Article

Search on Google

XML

PubMed Links